This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: The Innovations of Hans-Jurgen Legeler
Introduction
Hans-Jurgen Legeler is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with cytoprotective activity. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Hans-Jurgen Legeler holds a patent for "13-thiaprostaglandins having cytoprotective activity." This patent includes 13-thiaprostaglandins of Formula I, wherein B is either --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--. This invention represents a step forward in the search for effective therapeutic agents.
Career Highlights
Legeler is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a leading company in the pharmaceutical industry. His work at Merck has allowed him to focus on innovative solutions that address critical health challenges. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.
Collaborations
Throughout his career, Hans-Jurgen Legeler has collaborated with esteemed colleagues, including Bernd Simon and Hanns-Gerd Dammann. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Hans-Jurgen Legeler's contributions to the field of pharmaceuticals through his innovative patents highlight the vital role of inventors in advancing medical science. His work continues to inspire future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile